Benitec Biopharma Inc (BNTC)

Stock-Based Compensation

$6.26M

Quarterly · Period ending: · USD

BNTC logo

BNTC Stock-Based Compensation

Latest reported$6.26M
BNTC Quarterly Stock-Based Comp ($152.77K → $6.26M)
High-resolution chart · PNG

BNTC stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Benitec Biopharma Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
6,259,000
0
7,379,000
5,180,000
0
2,597,000
943,000
435,000
454,000
192,000
0
91,000
0
71,000
0
302,000
0
192,000
239,000
271,000
279,000
235,000
82,000
0
57,000
0
0
81,488
149,562
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
421,000
421,000
119,512
119,512
58,045
58,046
100,491
96,219
154,131
152,771
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.